top of page
Search
  • yvonne0039
    • Oct 27, 2021
    • 1 min read

Phase II “Study to Evaluate the Safety and Efficacy of Immune Killer Cells (IKC) in Stage IV Non-sma

Phase II Study to Evaluate the Safety and Efficacy of Immune Killer Cells (IKC®) in Stage IV Non-small Cell Lung Cancer (NSCLC) in Patients Who Failed Chemotherapy or Targeted Therapy


Clinical Trial Completed

46 views0 comments

Recent Posts

See All

Case Report

Cellular Immunotherapy with Immune Killer Cells for Treating a Lung Cancer Patient with Liver Metastasis Website Link: https://jmedscindmc.com/article.asp?issn=1011-4564;year=2022;volume=42;issue=3;sp

bottom of page